Advertisement

PentaVision

Ophthalmology Management

Article

Optimizing MIGS for Practice and Center Success

Done well, MIGS expands options for patients, improves predictability for the OR, and builds a durable glaucoma service line that strengthens the ASC.

By: Mitchell C. Shultz, MD
Ophthalmology Management July 1, 2026 Vol 30, Issue The Ophthalmic ASC July 2026 Page(s): 3-8
5 Key Takeaways

  • 1

    Minimally invasive glaucoma surgery (MIGS) is essential for enhancing clinical outcomes and operational efficiency in ambulatory surgical centers (ASCs).

  • 2

    MIGS complements high-volume cataract surgery and can be performed with minimal disruption, often taking only 3-8 additional minutes.

  • 3

    The iStent Infinite and Hydrus Microstent are FDA-cleared devices for treating refractory primary open-angle glaucoma in adults.

  • 4

    Operational efficiency in ASCs is crucial for profitability, and MIGS can be integrated without significantly affecting surgical schedules.

  • 5

    Sustained-release drug delivery systems like iDose TR and Durysta provide long-term intraocular pressure control and address patient compliance.